STOCK TITAN

Indiva to Report Third Quarter Results Pre-Market on Tuesday, November 22, 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

Indiva Limited (TSXV:NDVA; OTCQX:NDVAF), a leading Canadian cannabis producer, is set to release its financial results for the quarter ending September 30, 2022, on November 22, 2022, before the market opens. A conference call will follow at 8:30 AM (EST) to discuss these results, with participation available via phone. Indiva produces a variety of award-winning cannabis products, including Bhang Chocolate and Wana Sour Gummies, showcasing its commitment to quality and innovation.

Positive
  • None.
Negative
  • None.

LONDON, Ontario--(BUSINESS WIRE)-- Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), the leading Canadian producer of cannabis edibles and other cannabis products, will report its results for the quarter ended September 30, 2022 pre-market on Tuesday, November 22, 2022.

CONFERENCE CALL - Tuesday, November 22, 2022 at 8:30 a.m. (EST):

The Company will host a conference call to discuss its results on Tuesday, November 22, 2022 at 8:30 a.m. (EST). Interested participants can join by dialing 416-764-8658 or 1-888-886-7786. The conference ID is 70018162.

A recording of the conference call will be available for replay following the call. To access the recording please dial 416-764-8691 or 1-877-674-6060. The replay ID is 018162#. The recording will remain available until Thursday, December 22, 2022.

ABOUT INDIVA

Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva produces and distributes award-winning cannabis products nationally, including Bhang® Chocolate, Wana Sour Gummies, Jewels Chewable Tablets, Grön edibles, Dime IndustriesTM vape products, as well as capsules, edibles, extracts, pre-rolls and premium flower under the INDIVA, Indiva Life and Artisan Batch brands. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.

DISCLAIMER AND READER ADVISORY

General

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this news release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this news release or has in any way approved or disapproved of the contents of this news release.

Certain statements contained in this news release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this news release contains forward-looking information relating to the proposed telephone conference call expected to be held by the Company on November 22, 2022. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the Company. The forward-looking information contained in this news release is made as of the date hereof and the Company is not obligated to, and does not undertake to, update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions inherent in forward-looking information, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

INVESTOR CONTACT

Anthony Simone

Phone: 416-881-5154

Email: ir@indiva.com

Source: Indiva Limited

FAQ

When will Indiva report its Q3 2022 financial results?

Indiva will report its Q3 2022 financial results on November 22, 2022, before the market opens.

What time is the Indiva conference call for Q3 2022 results?

The Indiva conference call for Q3 2022 results is scheduled for November 22, 2022, at 8:30 AM (EST).

How can I participate in Indiva's Q3 2022 results conference call?

To participate in Indiva's Q3 2022 results conference call, dial 416-764-8658 or 1-888-886-7786 with conference ID 70018162.

What products does Indiva Limited produce?

Indiva Limited produces a wide range of cannabis products including edibles, vapes, capsules, extracts, and premium flower under various brands.

Where can I find more information about Indiva Limited?

More information about Indiva Limited and its products can be found on their official website or social media channels.

INDIVA LTD

OTC:NDVAF

NDVAF Rankings

NDVAF Latest News

NDVAF Stock Data

9.27M
115.31M
36.29%
0.06%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Ottawa